Dr. Lubna A. Al-Nasser
D. Lubna is a clinician-researcher, American-board certified public health dentist, and currently serves as the chairman of the Department of Population Health at King Abdullah International Medical Research Center (KAIMRC). She started her career as a dentist serving vulnerable and medically compromised patients; then completed her residency in advanced education in general dentistry, a master's degree in Public Health majoring in epidemiology and biostatistics, and assumed the position of associate consultant in dentistry at King Abdulaziz Medical City at the National Guard Health Affairs in Riyadh. At Columbia University, Lubna completed her residency in dental public health at the School of Dental Medicine and her Ph.D. in epidemiology from the Mailman School of Public Health, where she focused on the life-course approach and chronic diseases’ epidemiology. She joined the KAIMRC as an epidemiologist in 2022. During her research journey, Lubna worked on diverse research projects including primary care evaluation and needs assessment, oral medicine, dental anxiety and access to dental services, oral microbiome, mixed-methods research, the intersection of oral and systemic health, and global mental health. Currently, her work focuses on leveraging real-world data (RWD) for research purposes, social determinants of health, and the methodological applications of causal inference.
Dr. Hasan Al-Dorzi
Dr. Hasan Al-Dorzi is a highly qualified and experienced medical professional known for his expertise in critical care medicine and respiratory diseases. His impressive academic background includes a Bachelor of Science (BS) degree from the American University of Beirut in Lebanon in 1993, followed by a Doctor of Medicine (MD) degree in 1997 from the same institution. He has been serving as a Consultant in the Intensive Care Department at King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia since 2006, where he also holds the position of section head of adult ICU. Additionally, he is an Associate Professor at the College of Medicine, King Saud bin Abdulaziz University for Health Sciences in Riyadh, Saudi Arabia. Dr. Al-Dorzi's dedication to advancing the field of critical care medicine and respiratory diseases is evident through his extensive research contributions and his role as a consultant and educator. His work continues to have a significant impact on the medical community and the quality of care provided to critically ill patients. Dr. Al-Dorzi is a prolific clinical researcher with nearly 140 peer-reviewed articles and book chapters to his credit, focusing on critical care medicine and respiratory diseases, highlighting his significant contributions to the medical community.
Dr. Haifa M Algethamy
Dr. Haifa M Algethamy is an esteemed Associate Professor at the Faculty of Medicine and a Consultant in Anesthesia, Critical Care, and Neurocritical Care at the King Abdulaziz University Hospital in Jeddah, Saudi Arabia. She holds numerous leadership roles, such as being the Head of the Undergraduate Committee within the Department of Anesthesia & Critical Care at the Faculty of Medicine, King Abdulaziz University. Dr. Algethamy is also actively involved in various professional committees and editorial boards, including her membership in the National Brain Death Diagnosis Committee in Saudi Arabia and her role as the Head of the Saudi Neurocritical Care Research Committee within the Saudi Critical Care Society. In addition to her academic and clinical roles, Dr. Algethamy has an extensive educational background, including earning the Arab Board in Anesthesia and Intensive Care in 2002 and the Saudi Board in Anesthesia and Intensive Care in 2003. Furthermore, her commitment to continuous learning is evident through her clinical fellowships in Adult Critical Care Medicine and Neurocritical Care at the University of Western Ontario in London, Ontario, Canada, in 2009 and 2010, respectively. Dr. Algethamy's diverse experience and impressive qualifications solidify her standing as a leading figure in the field of critical care and neurocritical care.
Dr. Raghad Alhajaji
Dr. Raghad Alhajaji, a family medicine consultant at the Ministry of Health, holds certifications from the Saudi and Arab Boards of Family Medicine. As a Harvard Clinical Research Scholar, she emphasizes her research advisor and mentor roles in PubMed Axis publications. Proficient in clinical excellence, public health, infectious and chronic diseases, she actively engages in biostatistics, scientific writing, editing, and publishing. Dr. Alhajaji collaborates in research teaching, volunteers in medical education, and serves as a reviewer for scientific research journals.
Dr. Fatimah Abudayah
Fatimah Abudayah is an assistant professor in the Faculty of Nursing, in the Critical Care Nursing Department at King Abdulaziz University (KAU) in the Kingdom of Saudi Arabia (KSA). Dr. Abudayah earned her doctoral degree in Nursing from the University of Illinois at Chicago. She had a Bachelor's degree in nursing from KAU in 2006 and a Master’s degree from Rush University, Chicago, USA in 2013. Dr. Abudayah is a registered nurse in KSA and in the U.S. Dr. Abudayah was also inducted as a member of Sigma Theta Tau International, Honor Society of Nursing in 2016.
Dr. Afrah Alkazemi
Dr. Alkazemi is an assistant professor at Kuwait University's College of Pharmacy. She earned her Bachelor of Pharmacy degree from Kuwait University in 2008 and a Master of Science in Clinical Pharmacy, International Practice, and Policy from University College London in 2014. Continuing her academic endeavors, Dr. Alkazemi furthered her education with a Doctor of Pharmacy (PharmD) degree from MCPHS University, Boston, USA, in 2018. She then completed an ASHP accredited Postgraduate Year 1 (PGY1) Pharmacy Residency at BIDMC Hospital, Boston, USA, in 2019. Dr. Alkazemi has completed two clinical research pharmacy fellowships at Brigham and Women’s Hospital, Boston, USA. In 2020, she completed a fellowship in Quality and Safety, followed by a fellowship in Critical Care in 2021. Dr. Alkazemi has experience in clinical practice within hospital settings, coupled with publications concentrated in the realm of critical care.
Dr. Ahmed Aldemerdash
Dr. Aldemerdash is an assistant professor in the college of pharmacy, King Saud University, Saudi Arabia and cardiovascular pharmacotherapy pharmacy specialist in King Saud University Medical City. He also serves as the chairman of the Pharmacy Programs Unit, chairman of Pharmacy Fellowship Board, and director of the Cardiology Residency Program (PGY2) at KSUMC. Dr. Aldemerdash received a bachelor’s degree in pharmaceutical sciences from KSU and PharmD degree from MCPHS University, USA. He completed his PGY1 and PGY2-Cardiovascular pharmacotherapy residencies at Brigham and Women’s Hospital, USA. In addition, he completed cardiovascular pharmacotherapy fellowship in the University of North Carolina. He currently services as the Chairman of the Pharmacy Scientific Council at the Saudi Commission for Health Specialties and a board member in the Saudi Society of Clinical Pharmacy. His research areas includes cardiology, pharmacy and medical education, and postgraduate training.
Dr. Lama Nazer
Dr Nazer has over 20 years of experience in critical care at various institutions within the US and Jordan. She is actively involved with several local and international societies, including working with various committees of the Society of Critical Care Medicine and serving as the vice president and president of the Middle East Critical Care Association. She is a clinician, researcher, and educator, with a passion for capacity building. Her areas of research interest focus primarily on critically ill patients, with emphasis on critically ill oncology, sepsis, pharmacokinetics, and machine learning prediction models.
Dr. Omar Alshaya
Dr. Alshaya currently holds the position of Assistant Dean of Academic Affairs and serves as an Associate Professor of Pharmacy Practice at the College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences. Additionally, he works as a Consultant Clinical Pharmacist in Internal Medicine at King Abdulaziz Medical City in Riyadh. He earned his bachelor’s degree in pharmaceutical sciences from King Saud University in 2013 and obtained his Doctor of Pharmacy degree from the University of Illinois at Chicago in 2017. Dr. Alshaya completed his PGY-1 at Melrose-Wakefield Hospital in Boston, USA in 2018, and followed it with a PGY-2 specializing in internal medicine at Banner University Medical Center in Tucson, USA in 2019. Currently, he serves as the Chairperson of the Internal Medicine Pharmacy Specialty Network under the Saudi Society of Clinical Pharmacy.
Dr. Mohammed Alzahrani
Mohammed Alzahrani is a dedicated healthcare professional, holding a Doctor of Pharmacy degree from King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), where he graduated in 2017. Dr. Alzahrani's pursued further education in the United States. In 2021, he successfully graduated from the University of Health Sciences and Pharmacy in St. Louis. Dr. Alzahrani completed his PGY-1 (Postgraduate Year 1) training at the University of Illinois at Chicago, gaining invaluable experience in clinical pharmacy practice. Driven by a passion for oncology, Dr. Alzahrani pursued a PGY-2 (Postgraduate Year 2) specialization in oncology at the University of Arizona Cancer Center. Currently, Dr. Alzahrani serves in a dual role. As an Assistant Professor of Pharmacy Practice at KSAU-HS. Simultaneously, he is a Clinical Pharmacist specializing in Hematology and Oncology at King Abdulaziz Medical City (KAMC) in Riyadh.
Dr. Mohamed A. Albekery
Dr. Mohamed A. Albekery is an assistant professor in the Pharmacy Practice Department in the College of Clinical Pharmacy at King Faisal University and a Nephrology clinical pharmacy specialist at the National Guard Health Affairs, AlAhsa, Saudi Arabia. He completed his Pharm.D. degree from King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) in 2017. Dr. Albekery completed his postgraduate studies at King Abdulaziz Medical City-Riyadh. He completed PGY-1 in 2019, which has been accredited by the Saudi Commission for Health Specialties (SCFHS) and the American Society of Health System Pharmacists (ASHP) and completed his PGY-2 in Nephrology at King Abdulaziz Medical City in 2020. Dr. Albekery established clinical pharmacy services and was appointed as assistant head of clinical pharmacy services at King Fahad Military Medical City (KFMMC), Dhahran, Saudi Arabia. Also, he worked as clinical pharmacist in Nephrology and Critical Care field at KFMMC since March 2021 till July 2022, then he worked as clinical pharmacist in Nephrology and Critical Care field at Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia since August 2022 till April 2023. Dr. Albekery publishes in Nephrology related topics in peer-reviewed journals and presented multiple Nephrology-related topics at various conferences. Dr. Albekery is a Surveyor for training programs and centers accreditation at SCFHS, President of Alumni Board of Trustees in College of Pharmacy at KSAU-HS, and a member of various committees. Dr. Albekery has ASHP teaching certificate and Training of Trainers certificate from SCFHS.
Dr. Abdulmajeed Alshehri
Dr. Alshehri is an Assistant Professor in the Pharmacy Practice Department at King Saud bin Abdulaziz University for Health Sciences and a Critical Care Clinical Pharmacist at King Abdulaziz Medical City Riyadh, Saudi Arabia. Dr. Alshehri graduated from the College of Pharmacy at King Saud bin Abdulaziz University for Health Sciences and earned his Doctor of Pharmacy degree from the University of Health Sciences and Pharmacy in St. Louis, USA. Subsequently, he completed an ASHP accredited PGY-1 from Brigham and Women’s Hospital (BWH), followed by an ASHP accredited PGY-2 in Critical Care Pharmacotherapy from BWH, a Harvard affiliated hospital, Boston, USA. Dr. Alshehri is American board certified in critical care pharmacotherapy. Dr. Alshehri authored numerous peer-reviewed articles and presented on various critical care related topics at both national and international levels. He actively participates as a member of multiple committees within national and international organizations.
Dr. Haytham Abdulaziz Wali
Dr. Haytham Wali is a board-certified infectious disease pharmacist (BCIDP) and a clinical assistant professor of infectious diseases pharmacotherapy in the Department of Pharmacy Practice at King Faisal University College of Clinical Pharmacy in Al-Ahsa, Saudi Arabia. He completed his Doctor of Pharmacy (PharmD) degree at King Abdulaziz University Faculty of Pharmacy in Jeddah, Saudi Arabia, in 2011. Then, he completed the Certificate of Advanced Pharmacy Practice Studies (CAPPS) program at MCPHS University in Boston, Massachusetts, United States, in 2015, and the Advanced Clinical Pharmacy Practice Graduate Certificate program at The University of Arizona College of Pharmacy in Tucson, Arizona, United States, in 2018. He did his Post-graduate Year One (PGY1) pharmacy residency at Carondelet St. Joseph’s Hospital in Tucson, Arizona, United States, in 2020. Finally, he did his PGY2 infectious diseases residency at Piedmont Columbus Regional in Columbus, Georgia, United States, in 2021. His areas of interest include antimicrobial stewardship, antimicrobial resistance, antimicrobial dosing in special populations, and clinical microbiology. Dr. Wali is a member of the American College of Clinical Pharmacy (ACCP), the Infectious Diseases Society of America (IDSA), the Society of Infectious Diseases Pharmacists (SIDP), the American Society of Health-system Pharmacists (ASHP), and the Saudi Society of Clinical Pharmacy (SSCP). Dr. Wali has several publications in peer-reviewed journals. He is also an ad hoc reviewer for several scientific journals, including Antibiotics, the European Journal of Medical Research, the European Journal of Pediatrics, the International Journal of Infectious Diseases, the Journal of Clinical Nursing, and PloS One. Dr. Wali is the recipient of the 2023 Distinguished Junior Investigator Award by the Saudi Society of Clinical Pharmacy.
Dr. Shaimaa Alsulami
Dr. Shaimaa is an assistant professor of pharmacy practice and a pediatric clinical pharmacist. She completed her PharmD in 2016 from King Abdulaziz University in Jeddah. Then, she worked as a pharmacist at King Fahad Armed Forces Hospital in Jeddah. In 2018, she joined King Abdulaziz University Hospital as a PGY 1 resident. After that, in 2021, she completed her PGY 2 in pediatric pharmacotherapy at Abdulaziz Medical City, National Guard Health Affairs, Jeddah. She is an American board-certified specialist in pediatric pharmacotherapy. Moreover, she worked as a pediatric clinical pharmacist at King Fahad Armed Forces Hospital in Jeddah, covering the pediatric intensive care units and pediatric cardiac intensive care units. She also worked as the pharmacy residency program director from October 2021 until January 2024. She is currently a board member of the Pediatric Pharmacy Specialized Network (PSN) of the Saudi Society of Clinical Pharmacy (SSCP).